لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Le Moigne R; Cleave Biosciences, Inc., Burlingame, California. ronan.lemoigne29@gmail.com., Aftab BT; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., Djakovic S; Cleave Biosciences, Inc., Burlingame, California., Dhimolea E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Valle E; Cleave Biosciences, Inc., Burlingame, California., Murnane M; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., King EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Soriano F; Cleave Biosciences, Inc., Burlingame, California., Menon MK; Cleave Biosciences, Inc., Burlingame, California., Wu ZY; Cleave Biosciences, Inc., Burlingame, California., Wong ST; Cleave Biosciences, Inc., Burlingame, California., Lee GJ; Cleave Biosciences, Inc., Burlingame, California., Yao B; Cleave Biosciences, Inc., Burlingame, California., Wiita AP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California., Lam C; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California., Rice J; Cleave Biosciences, Inc., Burlingame, California., Wang J; Cleave Biosciences, Inc., Burlingame, California., Chesi M; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona., Bergsagel PL; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona., Kraus M; Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen, Switzerland., Driessen C; Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen, Switzerland., Kiss von Soly S; Cleave Biosciences, Inc., Burlingame, California., Yakes FM; Cleave Biosciences, Inc., Burlingame, California., Wustrow D; Cleave Biosciences, Inc., Burlingame, California., Shawver L; Cleave Biosciences, Inc., Burlingame, California., Zhou HJ; Cleave Biosciences, Inc., Burlingame, California., Martin TG 3rd; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., Wolf JL; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Anderson DJ; Cleave Biosciences, Inc., Burlingame, California., Rolfe M; Cleave Biosciences, Inc., Burlingame, California.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2017 Nov; Vol. 16 (11), pp. 2375-2386. Date of Electronic Publication: 2017 Sep 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Adenosine Triphosphatases/*genetics , Indoles/*administration & dosage , Multiple Myeloma/*drug therapy , Nuclear Proteins/*genetics , Nuclear Respiratory Factor 1/*genetics , Proteasome Inhibitors/*administration & dosage , Pyrimidines/*administration & dosage, Adenosine Triphosphatases/antagonists & inhibitors ; Animals ; Apoptosis/drug effects ; Cell Proliferation/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mice ; Multiple Myeloma/genetics ; Multiple Myeloma/pathology ; Nuclear Proteins/antagonists & inhibitors ; Proteasome Endopeptidase Complex/drug effects ; Ubiquitin/genetics ; Unfolded Protein Response/drug effects ; Xenograft Model Antitumor Assays